Ranok Therapeutics
Ranok Therapeutics uses of chaperone-mediated protein degraders (CHAMPs) against BRD4, a transcription factor that is implicated in cancer development.
1
Funding Rounds
$40.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ke*** P. Fo*** | - | - | - |
| We**** Yi** | - | - | - |
Funding series
Funding Series Analysis
The company Ranok Therapeutics has raised a total of $40m in funding over 1 rounds.
Key Insights:
- Ranok Therapeutics Series B round, August 2021: $40m
Ranok Therapeutics Series B round, August 2021
$40m
Industries
Ranok Therapeutics is active in the following industries: